Could tumor spread through air spaces benefit from adjuvant chemotherapy in stage I lung adenocarcinoma? A multi-institutional study

BACKGROUND: The benefit of adjuvant chemotherapy (ACT) remains unknown for patients with stage I lung adenocarcinoma (ADC) with spread through air spaces (STAS). This study investigated the effect of adjuvant chemotherapy in stage I ADC/STAS-positive patients. METHODS: A total of 3346 patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Donglai, Wang, Xiaofan, Zhang, Fuquan, Han, Ruoshuang, Ding, Qifeng, Xu, Xuejun, Shu, Jian, Ye, Fei, Shi, Li, Mao, Yiming, Chen, Yongbing, Chen, Chang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7739212/
https://www.ncbi.nlm.nih.gov/pubmed/33403018
http://dx.doi.org/10.1177/1758835920978147

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7739212/
https://www.ncbi.nlm.nih.gov/pubmed/33403018
http://dx.doi.org/10.1177/1758835920978147

Ejemplares similares